Filing Details
- Accession Number:
- 0001209191-21-008638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-08 20:25:26
- Reporting Period:
- 2021-02-04
- Accepted Time:
- 2021-02-08 20:25:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1733642 | San Pui Kwan | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Principal Acctg Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-04 | 1,389 | $10.86 | 4,621 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-04 | 1,125 | $11.02 | 5,746 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-04 | 833 | $9.04 | 6,579 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-04 | 3,347 | $65.00 | 3,232 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-04 | 1,389 | $0.00 | 1,389 | $10.86 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-04 | 1,125 | $0.00 | 1,125 | $11.02 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-02-04 | 833 | $0.00 | 833 | $9.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,286 | 2028-03-05 | No | 4 | M | Direct | |
25,875 | 2029-03-04 | No | 4 | M | Direct | |
26,667 | 2029-11-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- As of February 4, 2021, and prior to this transaction, the exercised options were fully vested.
- Not applicable.